Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q3 2021 · 10-Q
Revenue$46.76M$46.76M+7.1% vs Q3 2020 Net Income-$112.71M-$112.71MN/M vs Q3 2020 EPS Diluted-$0.96-$0.96N/M vs Q3 2020 Operating Income-$103,617,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$76,926,000N/M Margins · derivedOperating margin-221.6%−92.8 pt vs Q3 2020
Net margin-241.1%−95.2 pt vs Q3 2020
ended Sep 30, 2021 · filed Oct 28, 2021 · 28 d after period end